AbbVie suffers $15 million loss in Depakote birth-defect trial

(Reuters) - A federal jury on Friday awarded $15 million to a California woman who blamed her son's birth defects on AbbVie Inc's bipolar disorder drug Depakote, in the latest trial to spill out of hundreds of lawsuits over the drug.